MolNFT v1 · #179285 · protein
The crystal structure of the 2009/H1N1/CALIFORNIA pa endonuclease (construct with truncated loop 51-72) in complex with baloxavir acid
7K0W · Polymerase acidic protein: “The crystal structure of the 2009/H1N1/CALIFORNIA pa endonuclease (construct with truncated loop 51-72) in…”. X-ray diffraction, 3 ligands (E4Z, MN, SO4), 1 pocket (best druggability 0.66). MolNFT v1…
- PDB
- 7K0W
- Type
- protein
- Length
- 179 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Polymerase acidic protein
- EC
- 3.1.-.-
- UniProt
- C3W5S0
- Ligands
- E4Z, MN, SO4
- Pockets
- 1 · best druggability 0.66
Structure
x-ray diffraction · 1 distinct chain · 53% helix, 13% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Polymerase acidic protein (EC 3.1.-.-) | protein | 179 | 53% helix, 13% strand | C3W5S0 |
Ligands and binding sites
- E4Z · Baloxavir acid · ligand · chains A
- MN · Manganese (II) ion · metal · 2 copies · chains A
- SO4 · Sulfate ion · ion · 2 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 473 | 0.66 | 0.78 | 43 | E4Z, MN |
Compared structures
- 7K0W · The crystal structure of the 2009/H1N1/California PA endonuclease (construct with… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt C3W5S0
- Elsewhere: RCSB PDB 7K0W · PDBe 7K0W · UniProt C3W5S0
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.